SCHEMBL8258700

SCHEMBL8258700

Cc1ccc(-n2c(=O)c(Cl)c(C)n2C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPT P10636 2/20 0.48
USP2 O75604 2/20 0.48
GAA P10253 1/20 0.48
ALDH1A1 P00352 5/20 0.46
ALOX15 P16050 2/20 0.46
BCHE P06276 2/20 0.46
PTGS2 P35354 1/20 0.46
KMT2A Q03164 3/20 0.45
LMNA P02545 3/20 0.45
ADORA3 P0DMS8 1/20 0.45
POLB P06746 1/20 0.44
CYP1A2 P05177 1/20 0.44
THRB P10828 1/20 0.44
NAPRT Q6XQN6 1/20 0.44
FPR2 P25090 1/20 0.43
GLA P06280 1/20 0.43
MEN1 O00255 2/20 0.42
HSP90AA1 P07900 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4320077 0.89 GAA (0.50) TSHRMAPTGAAALDH1A1ALOX15
SCHEMBL4318702 0.86 KMT2A (0.51) TSHRGAAALDH1A1ALOX15BCHE
SCHEMBL29993 0.85 ALDH1A1 (0.64) TSHRKDM4EMAPTGAAALDH1A1
Hydrochloric Acid SCHEMBL28445202 0.84 ALDH1A1 (0.62) TSHRKDM4EMAPTGAAALDH1A1
SCHEMBL4321369 0.82 FPR2 (0.49) TSHRKDM4EMAPTGAAALDH1A1
SCHEMBL4322495 0.78 BRD9 (0.45) MAPTGAAALDH1A1ALOX15BCHE
SCHEMBL23907007 0.78 ALDH1A1 (0.46) TSHRKDM4EMAPTUSP2GAA
SCHEMBL6262072 0.78 BCHE (0.74) TSHRKDM4EMAPTUSP2GAA
SCHEMBL14946541 0.75 ALDH1A1 (0.47) TSHRKDM4EMAPTUSP2GAA
SCHEMBL13468170 0.74 GAA (0.50) TSHRMAPTGAAALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006071730-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS ASTRAZENECA AB (SE) 2006-07-06 WO disclosed